Vasoactive intestinal peptide and pituitary adenylate cyclase - Activating polypeptides (PACAP27 and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis

Blood

Volumn 87, Issue 12, 1996, Pages 5152-5161

  Delgado, Mario ^a   Garrido, Elvira ^a   Martínez, Carmen ^a   Leceta, Javier ^a   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; DNA FRAGMENT; GLUCOCORTICOID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DIAGNOSIS; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; THYMOCYTE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; APOPTOSIS; DEPRESSION, CHEMICAL; DEXAMETHASONE; DNA DAMAGE; MALE; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; T-LYMPHOCYTE SUBSETS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029891316     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5152.bloodjournal87125152     Document Type: Article

References (72)

1. McDonald HR, Lees RK: Programmed cell death of autoreactive thymocytes. Nature 343:642, 1990
2. Shi Y, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR: In vivo administration of antibodies to the CD3/T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol 146:3340, 1991
3. Smith CA, Willians GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181, 1989
4. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980
5. Cohen JJ, Duke RC: Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:128, 1984
6. Gerschenson LE, Rotelo RJ: Apoptosis: A different type of cell death. FASEB J 6:2450, 1992
7. Duvall E, Wyllie AH: Death and cell. Immunol Today 7:115, 1986
8. Sellins KS, Cohen JJ: Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139:3139, 1987
9. McKonkey DJ, Hartzell P, Nicotera P, Orrenius S: Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J 3:1843, 1989
10. Durant S, Homo F, Duval E: Calcium and A23187-induced cytolysis of mouse thymocytes. Biochem Biophys Res Commun 93:385, 1980
11. + thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351:150, 1991
12. lo thymocytes in vivo. Science 250:1720, 1990
13. Wyllie AH, Morris RG: Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol 109:78, 1982
14. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: Association with condensed chromatin, morphology and dependence on macromolecular synthesis. J Pathol 142:67, 1984
15. Wyllie AH, Kern JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
16. Pincus DW, DiCicco-Bloom E, Black IB: Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564, 1990
17. Brenneman DE, Westbrood GL, Firzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB: Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639, 1988
18. Gozes I, Brenneman DE: Neuropeptides as growth and differentation factors in general and VIP in particular. J Mol Neurosci 4:1, 1993
19. Xin Z, Tang H, Ganea D: Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via TCR/CD3 complex. J Neuroimmunol 54:59, 1994
20. Sun L, Ganea D: Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J Neuroimmunol 48:59, 1993
21. Delgado M, Martinez C, Leceta J, Garrido E, Gomariz RP: Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets. Peptides (in press)
22. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler M, Coy DH: Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567, 1989
23. Tatsuno Y, Gottschall PE, Arimura A: Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: A comparative study with vasoactive intestinal peptide. Endocrinology 238:728, 1991.
24. Delgado M, De la Fuente M, Martinez C, Gomariz RP: Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: Comparison with VIP and implication of cAMP. J Neuroimmunol 62:137, 1995
25. Mossman T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
26. Perandones CE, Illera VA, Peckham D, Stunz LL, Ashman RF: Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol 151:3521, 1993
27. Burton K: A study of the conditions and mechanism of diphenylamide reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315, 1956
28. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
29. 2 as a VIP antagonist. Endocrinology 116:2643, 1985
30. Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE: Growth factor of vasoactive intestinal peptide in wholecultured mouse embryos. Nature 362:155, 1993
31. Pincus DW, DiCicco-Bloom E, Black IB: Trophic mechanisms regulate mitotic neuronal precursors: Role of vasoactive intestinal peptide (VIP). Brain Res 663:51, 1994
32. Goosens JF, Manechez D, Pommery N, Formstecher P, Henichart JP: VIP potentiates retinoic-acid effect on tissue transglutaminase activity in human neuroblastoma, the SK-N-SH cells. Neuropeptides 24:99, 1993
33. Ernström U, Gafvelim G, Mutt V: Rescue of thymocytes from cell death by vasoactive intestinal peptide. Regul Pept 57:99, 1995
34. Duke RCR, Chevenak R, Cohen JJ: Endogenous endonuclease-induced DNA fragmentation: An early event in cell mediated cytolysis. Proc Natl Acad Sci USA 80:6361, 1983
35. Mogil RJ, Shi Y, Bissonnette RP, Bromley BP, Yamaguchi I, Green DR: Role of DNA fragmentation in T cell activation-induced apoptosis in vitro and in vivo. J Immunol 152:1674, 1994
36. Calvo JR, Guerrero JM, Molinero P, Blasco R, Goberna R: Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: Specific binding and cyclic AMP production. Gen Pharmacol 17:185, 1986
37. Ottaway CA: Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly. J Neuroimmunol 38:241, 1992
38. Mody R, Tramontano A, Paul S: Spontaneous hydrolysis of vasoactive intestinal peptide in neutral aqueous solution. Int J Peptide Protein Res 44:441, 1994
39. Goetzl EJ, Kodama KT, Turck CW, Schiogolev SA, Sreedharan SP: Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes. Immunology 66:554, 1989
40. Moore TC, Spruck CH, Said SI: Depression of lymphocyte traffic in sheep by VIP. Immunology 64:475, 1988
41. Robichon A, Sreedharan SP, Yang J, Shames RS, Gronroos EC, Cheng PPJ, Goetzl EJ: Induction of aggregation of Raji human B cells by VIP. Immunology 79:574, 1993
42. De la Fuente M, Delgado M, Del Rio M, Garrido E, Leceta J, Hernanz A, Gomariz RP: Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. Peptides 15:1157, 1994
43. Ottaway CA, Greenberg GR: Interaction of vasoactive intestinal peptide with mouse lymphocytes. J Immunol 132:417, 1984
44. Krco TJ, Gores A, Go VLW: Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Clin Immunol Immunopathol 39:308, 1986
45. Tang SC, Braunsteiner H, Wiedermann CJ: Regulation of human T lymphoblast growth by sensory neuropeptides: Augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide. Immunology Lett 34:237, 1992
46. Ottaway CA: Selective effect of VIP on the mitogenic response of murine T cells. Immunology 62:291, 1987
47. Boudard F, Bastide M: Inhibition of mouse T cell proliferation by CGRP and VIP. J Neurosci Res 29:29, 1991
48. Ganea D, Sun L: Vasoactive intestinal peptide downregulates the expression of IL-2 but not IFN gamma from stimulated murine T lymphocytes. J Neuroimmunol 47:147, 1993
49. Nio DA, Moylan RN, Roche JK: Modulation of T lymphocyte function by neuropeptides. J Immunol 150:5281, 1993
50. Stanisz AM, Befus D, Bienenstodk J: Differential effects of vasoactive intestinal peptide, substance P and somatostatin on Ig synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. J Immunol 136:152, 1986
51. Rola-Pleszczynski M, Bolduc D, St-Pierre A: The effect of VIP on NK function. J Immunol 135:4078, 1985
52. Wiik P: Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by cAMP-mediated mechanism. Regul Pept 25:187, 1989
53. De la Fuente M, Delgado M, Del Rio M, Martinez C, Hernanz A, Gomariz RP: Stimulation by vasoactive intestinal peptide of phagocytic function in rat peritoneal macrophages. Involvement of protein kinase C activity. Regul Pept 48:345, 1993
54. Ichinose M, Sawada M, Maeno T: Inhibitory effect of VIP on phagocytosis in mouse peritoneal macrophages. Regul Pept 54:457, 1994
55. Ottaway CA, Lay TE, Greenberg GR: High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes. J Neuroimmunol 29:149, 1990
56. Gomariz RP, Garrido E, Leceta J, Martinez C, Abalo R, Delgado M: Gene expression of VIP receptor in rat lymphocytes. Biochem Biophys Res Commun 203:1599, 1994
57. Shivers BD, Görcs TJ, Gottschall PE, Arimura A: Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 128:3055, 1991
58. Evan GI, Brown L, Whyte M, Harrington E: Apoptosis and the cell cycle. Curr Opin Cell Biol 7:825, 1995
59. Kim SW, Bauchamp D, Townsend CM, Thompson JC: Vasoactive intestinal peptide inhibits c-myc expression and growth of human gastric carcinoma cells. Surgery 110:270, 1991
60. Derynck R, Wagner EF: Cell differentiation. Curr Opin Cell Biol 7:842, 1995
61. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki J, Susumu S: Cloning and functional characterization of a third PACAP receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci USA 91:2679, 1994
62. Svoboda M, Tastenoy M, Van Rampelbergh J, Boosens J-F, De Neef P, Waelbroeck M, Robberech P: Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun 205:1617, 1994
63. Arimura A: Pituitary adenylate cyclase-activating polypeptide (PACAP): Discovery and current states of research. Regul Pept 37:287, 1992
64. Usdin TB, Bonner TI, Mezey E: Two receptors for vasoactive intestinal peptide with similar specificity and complementary distributions. Endocrinology 135:2662, 1994
65. Screpanti I, Morrone S, Meco D, Santoni A, Gulino A, Paolini R, Crisanti A, Mathieson BI, Frati L: Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol 142:3378, 1989
66. Migliorati G, Nicoletti I, Pagliacci MC, D'Adamio L, Riccardi C: Interleukin 4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81:1352, 1993
67. Reichert RA, Weissman IL, Butcher EC: Dual immunofluorescence studies of cortisone-induced thymic involution: Evidence for a major cortical component to cortisone-resistant thymocytes. J Immunol 136:3529, 1986
68. 2+ concentration. Arch Biochem Biophys 269:365, 1989
69. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S: Noradrenergic and peptidergic innervation of lymphoid tissues. J Immunol 135:755s, 1985
70. Leceta J, Martinez C, Delgado M, Garrido E, Gomariz RP: Lymphoid cell subpopulations containing vasoactive intestinal peptide in the rat. Peptides 15:791, 1994
71. Gomariz RP, Leceta J, Garrido E, Garrido T, Delgado M: VIP mRNA expression in rat T and B lymphocytes. Regul Pept 6:8, 1994
72. Gaytan F, Martinez-Fuentes AJ, Garcia-Navarro F, Vaudry H, Aguilar E: Pituitary adenylate cyclase-activating polypeptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res 276:233, 1994